OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA lipid nanoparticles induce immune tolerance to treat human diseases
Wei Cao, Tian Xia
Medical Review (2023) Vol. 3, Iss. 2, pp. 180-183
Open Access | Times Cited: 8
Wei Cao, Tian Xia
Medical Review (2023) Vol. 3, Iss. 2, pp. 180-183
Open Access | Times Cited: 8
Showing 8 citing articles:
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 51
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 51
Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis
Tetiana Korzun, Abraham S. Moses, Antony Jozić, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24842-24859
Closed Access | Times Cited: 4
Tetiana Korzun, Abraham S. Moses, Antony Jozić, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24842-24859
Closed Access | Times Cited: 4
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance
Sydney Kusumoputro, Christian Au, Katie H. Lam, et al.
Nanomaterials (2023) Vol. 14, Iss. 1, pp. 67-67
Open Access | Times Cited: 6
Sydney Kusumoputro, Christian Au, Katie H. Lam, et al.
Nanomaterials (2023) Vol. 14, Iss. 1, pp. 67-67
Open Access | Times Cited: 6
Optimized strategies for precise messenger RNA delivery using site-specific lipid nanoparticle-based drug delivery systems
Wei Cao, Tian Xia
Nanomedicine (2024), pp. 1-4
Closed Access
Wei Cao, Tian Xia
Nanomedicine (2024), pp. 1-4
Closed Access
Regulating Immune Responses Induced by PEGylated Messenger RNA–Lipid Nanoparticle Vaccine
Hyein Jo, Jaewhoon Jeoung, Won‐Ho Kim, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 14-14
Open Access
Hyein Jo, Jaewhoon Jeoung, Won‐Ho Kim, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 14-14
Open Access
Lipid Nanoparticle (LNP) Delivery Vector-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
